annual EBITDA:
$10.48B-$8.00M(-0.08%)Summary
- As of today (August 5, 2025), ELV annual EBITDA is $10.48 billion, with the most recent change of -$8.00 million (-0.08%) on December 31, 2024.
- During the last 3 years, ELV annual EBITDA has risen by +$387.00 million (+3.83%).
- ELV annual EBITDA is now -0.08% below its all-time high of $10.49 billion, reached on December 31, 2023.
Performance
ELV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$3.01B-$501.00M(-14.26%)Summary
- As of today (August 5, 2025), ELV quarterly EBITDA is $3.01 billion, with the most recent change of -$501.00 million (-14.26%) on June 30, 2025.
- Over the past year, ELV quarterly EBITDA has dropped by -$588.00 million (-16.33%).
- ELV quarterly EBITDA is now -38.74% below its all-time high of $4.92 billion, reached on December 31, 2009.
Performance
ELV quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$9.87B-$588.00M(-5.62%)Summary
- As of today (August 5, 2025), ELV TTM EBITDA is $9.87 billion, with the most recent change of -$588.00 million (-5.62%) on June 30, 2025.
- Over the past year, ELV TTM EBITDA has dropped by -$1.29 billion (-11.52%).
- ELV TTM EBITDA is now -11.52% below its all-time high of $11.16 billion, reached on June 30, 2024.
Performance
ELV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ELV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | -16.3% | -11.5% |
| 3 y3 years | +3.8% | +10.7% | -2.9% |
| 5 y5 years | +33.3% | -17.1% | +1.8% |
ELV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +3.8% | -16.3% | +124.2% | -11.5% | at low |
| 5 y | 5-year | -0.1% | +33.3% | -17.1% | +236.7% | -11.5% | +31.6% |
| alltime | all time | -0.1% | +4002.5% | -38.7% | +770.9% | -11.5% | >+9999.0% |
ELV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $3.01B(-14.3%) | $9.87B(-5.6%) |
| Mar 2025 | - | $3.51B(+161.5%) | $10.46B(-0.2%) |
| Dec 2024 | $10.48B(-0.1%) | $1.34B(-32.9%) | $10.48B(-3.1%) |
| Sep 2024 | - | $2.00B(-44.4%) | $10.82B(-3.0%) |
| Jun 2024 | - | $3.60B(+1.9%) | $11.16B(+4.4%) |
| Mar 2024 | - | $3.54B(+109.9%) | $10.69B(+1.9%) |
| Dec 2023 | $10.49B(+3.6%) | $1.68B(-28.0%) | $10.49B(-0.6%) |
| Sep 2023 | - | $2.34B(-25.4%) | $10.55B(-4.1%) |
| Jun 2023 | - | $3.13B(-5.9%) | $11.01B(+3.9%) |
| Mar 2023 | - | $3.33B(+90.7%) | $10.59B(+4.6%) |
| Dec 2022 | $10.13B(+0.3%) | $1.75B(-37.4%) | $10.13B(-2.7%) |
| Sep 2022 | - | $2.79B(+2.5%) | $10.41B(+2.4%) |
| Jun 2022 | - | $2.72B(-5.0%) | $10.17B(-1.4%) |
| Mar 2022 | - | $2.87B(+41.1%) | $10.31B(+2.1%) |
| Dec 2021 | $10.10B(+23.5%) | $2.03B(-20.3%) | $10.10B(+10.2%) |
| Sep 2021 | - | $2.55B(-11.1%) | $9.16B(+22.0%) |
| Jun 2021 | - | $2.87B(+8.2%) | $7.50B(-9.3%) |
| Mar 2021 | - | $2.65B(+142.7%) | $8.27B(+1.2%) |
| Dec 2020 | $8.18B(+4.0%) | $1.09B(+22.0%) | $8.18B(-5.1%) |
| Sep 2020 | - | $895.00M(-75.4%) | $8.62B(-11.1%) |
| Jun 2020 | - | $3.64B(+42.4%) | $9.70B(+21.3%) |
| Mar 2020 | - | $2.55B(+66.4%) | $8.00B(+1.7%) |
| Dec 2019 | $7.86B(+13.1%) | $1.53B(-22.3%) | $7.86B(+7.0%) |
| Sep 2019 | - | $1.98B(+2.1%) | $7.35B(+3.6%) |
| Jun 2019 | - | $1.93B(-20.1%) | $7.09B(-0.7%) |
| Mar 2019 | - | $2.42B(+137.4%) | $7.14B(+2.7%) |
| Dec 2018 | $6.95B(+24.3%) | $1.02B(-40.6%) | $6.95B(+7.8%) |
| Sep 2018 | - | $1.72B(-13.3%) | $6.45B(+3.6%) |
| Jun 2018 | - | $1.98B(-11.3%) | $6.22B(+6.3%) |
| Mar 2018 | - | $2.23B(+332.9%) | $5.86B(+4.7%) |
| Dec 2017 | $5.59B(-9.6%) | $516.00M(-65.4%) | $5.59B(-9.0%) |
| Sep 2017 | - | $1.49B(-7.6%) | $6.15B(-0.7%) |
| Jun 2017 | - | $1.61B(-18.1%) | $6.19B(-3.8%) |
| Mar 2017 | - | $1.97B(+84.5%) | $6.44B(+4.0%) |
| Dec 2016 | $6.19B(-0.0%) | $1.07B(-30.5%) | $6.19B(+4.8%) |
| Sep 2016 | - | $1.54B(-17.3%) | $5.91B(+4.8%) |
| Jun 2016 | - | $1.86B(+7.9%) | $5.63B(-5.8%) |
| Mar 2016 | - | $1.72B(+119.6%) | $5.98B(-3.4%) |
| Dec 2015 | $6.19B(+6.4%) | $785.30M(-37.9%) | $6.19B(-7.0%) |
| Sep 2015 | - | $1.27B(-42.6%) | $6.66B(-2.7%) |
| Jun 2015 | - | $2.20B(+13.7%) | $6.84B(+9.2%) |
| Mar 2015 | - | $1.94B(+55.2%) | $6.26B(+7.6%) |
| Dec 2014 | $5.82B | $1.25B(-13.9%) | $5.82B(+7.3%) |
| Sep 2014 | - | $1.45B(-10.9%) | $5.42B(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $1.63B(+9.0%) | $5.24B(+0.8%) |
| Mar 2014 | - | $1.49B(+74.9%) | $5.20B(-2.9%) |
| Dec 2013 | $5.35B(+4.7%) | $853.40M(-32.4%) | $5.35B(+0.7%) |
| Sep 2013 | - | $1.26B(-20.5%) | $5.32B(-1.6%) |
| Jun 2013 | - | $1.59B(-3.6%) | $5.40B(+4.6%) |
| Mar 2013 | - | $1.65B(+101.3%) | $5.16B(+1.0%) |
| Dec 2012 | $5.11B(+1.7%) | $818.80M(-39.2%) | $5.11B(+1.0%) |
| Sep 2012 | - | $1.35B(-0.1%) | $5.06B(+0.8%) |
| Jun 2012 | - | $1.35B(-15.6%) | $5.02B(+1.7%) |
| Mar 2012 | - | $1.60B(+107.3%) | $4.94B(-1.7%) |
| Dec 2011 | $5.03B(-6.5%) | $770.60M(-41.0%) | $5.03B(-4.8%) |
| Sep 2011 | - | $1.31B(+3.1%) | $5.28B(-1.7%) |
| Jun 2011 | - | $1.27B(-24.8%) | $5.37B(-2.0%) |
| Mar 2011 | - | $1.68B(+64.5%) | $5.48B(+2.0%) |
| Dec 2010 | $5.37B(-36.1%) | $1.02B(-26.8%) | $5.37B(-42.0%) |
| Sep 2010 | - | $1.40B(+1.6%) | $9.27B(+1.6%) |
| Jun 2010 | - | $1.38B(-12.5%) | $9.12B(+2.0%) |
| Mar 2010 | - | $1.57B(-68.0%) | $8.94B(+6.4%) |
| Dec 2009 | $8.40B(+101.8%) | $4.92B(+292.1%) | $8.40B(+82.6%) |
| Sep 2009 | - | $1.25B(+4.9%) | $4.60B(+13.8%) |
| Jun 2009 | - | $1.20B(+15.4%) | $4.04B(-3.2%) |
| Mar 2009 | - | $1.04B(-7.2%) | $4.18B(+0.3%) |
| Dec 2008 | $4.16B(-28.5%) | $1.12B(+60.8%) | $4.16B(-8.0%) |
| Sep 2008 | - | $694.60M(-47.7%) | $4.52B(-15.4%) |
| Jun 2008 | - | $1.33B(+29.7%) | $5.35B(-2.2%) |
| Mar 2008 | - | $1.02B(-30.7%) | $5.47B(-6.1%) |
| Dec 2007 | $5.83B(+6.9%) | $1.48B(-2.8%) | $5.83B(+7.6%) |
| Sep 2007 | - | $1.52B(+4.9%) | $5.42B(+0.1%) |
| Jun 2007 | - | $1.45B(+4.9%) | $5.41B(-2.2%) |
| Mar 2007 | - | $1.38B(+29.5%) | $5.53B(+1.5%) |
| Dec 2006 | $5.45B(+14.7%) | $1.07B(-29.4%) | $5.45B(-9.6%) |
| Sep 2006 | - | $1.51B(-3.8%) | $6.03B(+7.2%) |
| Jun 2006 | - | $1.57B(+20.7%) | $5.63B(+11.5%) |
| Mar 2006 | - | $1.30B(-20.8%) | $5.05B(+6.2%) |
| Dec 2005 | $4.75B(+154.7%) | $1.64B(+48.2%) | $4.75B(+30.1%) |
| Sep 2005 | - | $1.11B(+11.8%) | $3.65B(+25.0%) |
| Jun 2005 | - | $991.90M(-1.3%) | $2.92B(+22.4%) |
| Mar 2005 | - | $1.01B(+84.1%) | $2.39B(+28.1%) |
| Dec 2004 | $1.86B(+629.8%) | $546.10M(+44.1%) | $1.86B(+41.4%) |
| Sep 2004 | - | $379.10M(-17.1%) | $1.32B(+40.4%) |
| Jun 2004 | - | $457.50M(-5.1%) | $939.50M(+94.9%) |
| Mar 2004 | - | $482.00M(-207.3%) | $482.00M(+445.2%) |
| Dec 2002 | $255.50M | -$449.10M(-247.3%) | $88.40M(-83.6%) |
| Sep 2002 | - | $304.80M(+31.0%) | $537.50M(+131.0%) |
| Jun 2002 | - | $232.70M | $232.70M |
FAQ
- What is Elevance Health, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Elevance Health, Inc.?
- What is Elevance Health, Inc. annual EBITDA year-on-year change?
- What is Elevance Health, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Elevance Health, Inc.?
- What is Elevance Health, Inc. quarterly EBITDA year-on-year change?
- What is Elevance Health, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Elevance Health, Inc.?
- What is Elevance Health, Inc. TTM EBITDA year-on-year change?
What is Elevance Health, Inc. annual EBITDA?
The current annual EBITDA of ELV is $10.48B
What is the all time high annual EBITDA for Elevance Health, Inc.?
Elevance Health, Inc. all-time high annual EBITDA is $10.49B
What is Elevance Health, Inc. annual EBITDA year-on-year change?
Over the past year, ELV annual EBITDA has changed by -$8.00M (-0.08%)
What is Elevance Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of ELV is $3.01B
What is the all time high quarterly EBITDA for Elevance Health, Inc.?
Elevance Health, Inc. all-time high quarterly EBITDA is $4.92B
What is Elevance Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, ELV quarterly EBITDA has changed by -$588.00M (-16.33%)
What is Elevance Health, Inc. TTM EBITDA?
The current TTM EBITDA of ELV is $9.87B
What is the all time high TTM EBITDA for Elevance Health, Inc.?
Elevance Health, Inc. all-time high TTM EBITDA is $11.16B
What is Elevance Health, Inc. TTM EBITDA year-on-year change?
Over the past year, ELV TTM EBITDA has changed by -$1.29B (-11.52%)